Brazil Scraps Covaxin Application for Authorisation as Former Partner Attacks Bharat Biotech
Bharat Biotech s application for EUA approval has been binned and permission for clinical trials suspended.
File photo of Prime Minister Narendra Modi at the Bharat Biotech plant in November 2020. At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine. Congratulated the scientists for their progress in the trials so far. Their team is closely working with ICMR to facilitate speedy progress, Modi had tweeted at the time,
World17 hours ago
São Paulo: Indian pharmaceutical giant Bharat Biotechâs ambitious plans to sell millions of doses of its highly-priced vaccine, Covaxin, to Brazil all but crashed on Saturday after the National Health Surveillance Agency (ANVISA) decided to scrap the companyâs application for emergency use authorisation (EUA).
Estados de Brasil preparan la llegada de Sputnik V con agencia reguladora sputniknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sputniknews.com Daily Mail and Mail on Sunday newspapers.
Brazil s health regulator rejected the vaccine brand from Russia amid the surge of COVID cases and deaths in the country. Because of this decision, the developers of Sputnik V coronavirus vaccine criticized the country when they refused to import the said brand, Al Jazeera reported.
The country s refusal of the vaccine doses from Russia comes as Brazil Senate pushes through with a probe against their president regarding his handling of the issue. President Jair Bolsonaro was reported to have downplayed the pandemic s threat as he refused lockdowns, arguing that the economic impact would harm the country more than the virus.
Agencia reguladora brasileña niega permiso a la Sputnik V paginasiete.bo - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from paginasiete.bo Daily Mail and Mail on Sunday newspapers.